Financiado en parte por Egg Nutrition Center, Canadian Dairy Commission, American Egg Board
Egg Consumption in the Context of Plant-Based Diets and Cardiometabolic Risk Factors in Adults at Risk of Type 2 Diabetes
Njike VY, Treu JA, Kela GCM, Ayettey RG, Comerford BP, Siddiqui WT
The Journal of nutrition · 8 citas
Etiquetas de revisión
Financiado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
- Consumo medido con
- No se indica
Quién lo pagó
- Financiación
- Financiado por la industria
- Grupo de la industria
- Egg Nutrition Center
- Grupo de la industria
- Canadian Dairy Commission
- Gobierno
- Centers for Disease Control and Prevention
- Gobierno
- CDC HHS
- Gobierno
- CDC
- Grupo de la industria
- American Egg Board
Según 6 financiadores declarados.
Publicación
- Publicado
- 2021-08-04 · J Nutr · vol. 151 · número 12 · págs. 3651–3660
- Editorial
- Elsevier BV
- Citado
- 8 citas · más que el 78% de estudios similares · 1.2× el promedio de su campo
- Referencias
- 28 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Nutritional Studies and Diet · Agriculture Sustainability and Environmental Impact · Diabetes, Cardiovascular Risks, and Lipoproteins
- Palabras clave
- egg consumption, plant-based diet, type 2 diabetes risk, cardiometabolic risk factors, endothelial function, flow-mediated dilation, lipid profile, blood pressure, insulin sensitivity, dietary selenium intake, choline intake, nutrition counseling
- MeSH
- humans, diabetes mellitus, type 2, diet, risk factors, single-blind method, diet, vegetarian, eggs, adult, middle aged, female, male, cardiometabolic risk factors
6 autores
- Valentine Yanchou Njike🇺🇸 · autor de correspondenciaGriffin Hospital; Yale Griffin Prevention Research Center
- Judith A. Treu🇺🇸Yale Griffin Prevention Research Center
- Genevieve Kela🇺🇸Griffin Hospital; Yale Griffin Prevention Research Center
- Rockiy G. Ayettey🇺🇸Yale Griffin Prevention Research Center
- Beth Patton Comerford🇺🇸Yale Griffin Prevention Research Center
- Waleed Tariq Siddiqui🇺🇸Griffin Hospital; Yale Griffin Prevention Research Center
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Plant-based diets (PBDs) are typically recommended to those at risk of type 2 diabetes mellitus (T2DM).
Objectives
We examined how including eggs, compared with excluding them from PBDs, affected cardiometabolic risk factors in adults at risk of T2DM.
Methods
This was a randomized, controlled, single-blind, crossover trial of 35 adults (mean age: 60.7 y; 25 women, 10 men) at risk of T2DM assigned to 1 of 2 sequence permutations of 2 dietary treatments (plant-based plus eggs, and exclusively plant-based), with a 4-wk washout period. A dietitian counseled participants to exclude or include 2 eggs daily in the context of PBDs for a 6-wk interval. Our primary outcome measure was endothelial function (EF) measured as flow-mediated dilatation. Secondary outcome measures included lipid profile, blood pressure, insulin sensitivity, anthropometry, and dietary intake. Data were analyzed using generalized linear models.
Results
Compared with egg exclusion, egg inclusion in the context of PBDs did not adversely affect EF (-1.7% ± 6.5% compared with -1.8% ± 7.5%; P = 0.9805). Likewise, egg inclusion, compared with egg exclusion, did not adversely affect (P = 0.1096-0.9781) lipid profile, blood pressure, insulin sensitivity, or anthropometry. Egg inclusion, compared with egg exclusion, improved reported intakes of selenium (23.1 ± 30.3 μg/d compared with 2.3 ± 34.9 μg/d; P = 0.0124) and choline (172.0 ± 96.0 mg/d compared with -3.4 ± 68.1 mg/d; P < 0.0001).
Conclusions
Consuming 2 eggs daily in the context of PBDs does not adversely affect cardiometabolic risk factors among adults at risk of T2DM. Eggs could be used as an adjuvant to enhance PBDs that are typically recommended for those at risk of T2DM.This trial was registered at clinicaltrials.gov as NCT04316429.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.